Peter Garcia

Overview

Peter Garcia received an average of $3M in total compensation, including $460K in salary, at ALX ONCOLOGY HOLDINGS between 2021 and 2022. Peter Garcia also received an average of $2M at PDL BioPharma from 2013 to 2019.

Related executives

We found 19 more executives who work or worked at ALX ONCOLOGY HOLDINGS and PDL BioPharma.

Jaume Pons

ALX ONCOLOGY HOLDINGS

Chief Executive Officer

Sophia Randolph

ALX ONCOLOGY HOLDINGS

Chief Medical Officer

Dominique Monnet

PDL BioPharma

Chief Executive Officer

Christopher Stone

PDL BioPharma

General Counsel

Jill Jene

PDL BioPharma

Vice President, Business Development

Edward Imbrogno

PDL BioPharma

Chief Financial Officer

John McLaughlin

PDL BioPharma

Chief Executive Officer

Danny Hart

PDL BioPharma

Vice President, Business Development

News

You may also like